DAX
Siemens Energy Nears First Buyback Limit as Saudi Mega-Plants Begin Operations
The industrial conglomerate is juggling two major milestones simultaneously. Siemens Energy has almost exhausted the first €2bn tranche of its...
Siemens Healthineers Shares Test Support After China Diagnostics Hit Sinks Earnings and Guidance
The structural breakdown in China’s diagnostics market has sent Siemens Healthineers shares spiralling to their weakest level in a year,...
Munich Re’s Earnings Surge and a Trimmed Target: Two Signals, One Bullish Bet
Shares of Munich Re have clawed back from their lowest point in a year, adding 2.85% over the past week...
BMW Rewires Its Capital Structure: Preference Shares Go, Buyback Continues, but China Clouds Remain
Shareholders of BMW have voted overwhelmingly to scrap the company’s dual-class equity structure, converting all non-voting preference shares into ordinary...
Siemens Energy Posts €835 Million Quarterly Profit, Doubles Cash Flow Target as AI and Grid Expansion Fuel Record Orders
The turnaround at Siemens Energy is gathering pace. The industrial group reported a net profit of €835 million for its...
Siemens Flips the Switch on a Microgrid Milestone as Energy Tailwinds Propel Shares Toward Record High
The sprawling plant floor at Siemens’ US electrification headquarters in Wendell, North Carolina, is now running on a self-contained power...
Munich Re Faces a Twin Agenda: A New CEO’s M&A Push and a Looming Cyber Threat
The annual general meeting of Munich Re in Munich is set to be anything but routine. For the first time,...
German Stocks Face a Four-Day Gauntlet of Earnings, Central Banks and Geopolitical Risk
The DAX enters a compressed trading week nursing a 2.3 percent decline, having closed Friday at 24,129 points — just...
Rheinmetall’s €2.4 Billion Drone Deal Can’t Lift Shares From a 52-Week Low
The Düsseldorf-based defence group is churning out artillery shells, military trucks and loitering munitions at record pace, yet its stock...
Bayer’s €7 Billion Insurance Policy: Shareholders Back a Capital Cushion for the Glyphosate Endgame
Bayer’s annual general meeting on April 24 was a study in contradictions. Major institutional investors praised CEO Bill Anderson’s restructuring...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
